Health Outcomes, Epidemiology, and Risk Management

Coram Clinical Trials provides expertise for a broad range of health outcomes studies that examine the clinical, economic, and quality-of-life outcomes of drug products.  

We can assist your team in the conduct of research to support publication and gain critical insight into your drug’s therapeutic value throughout its lifecycle.

Clinical, behavioral, humanistic, and economic endpoints can be gathered and measured at various points throughout the drug development process. Let Coram Clinical Trials help you gain critical insight through:

• Documentation of epidemiology aspects  and cost burden of a particular disease state
• Research services, as a compound moves forward to Phase II - IIIb, behavioral, humanistic, and economic endpoints may be incorporated into registration trials
• Economic models may be created to quantify the economic benefit of the new therapy
• Post-launch research services including registries, Phase IIIb - IV comparative studies, and claims analyses